Achieve Life Sciences Stock Current Valuation
| ACHV Stock | USD 4.49 0.01 0.22% |
Valuation analysis of Achieve Life Sciences helps investors to measure Achieve Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to climb to about 87 M in 2024, despite the fact that Enterprise Value Over EBITDA is likely to grow to (2.94). Fundamental drivers impacting Achieve Life's valuation include:
Price Book 4.91 | Enterprise Value 121 M | Enterprise Value Ebitda (2.42) |
Overvalued
Today
Please note that Achieve Life's price fluctuation is moderately volatile at this time. Calculation of the real value of Achieve Life Sciences is based on 3 months time horizon. Increasing Achieve Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Achieve stock is determined by what a typical buyer is willing to pay for full or partial control of Achieve Life Sciences. Since Achieve Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Achieve Stock. However, Achieve Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.49 | Real 3.86 | Target 28.57 | Hype 4.48 | Naive 4.48 |
The intrinsic value of Achieve Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Achieve Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Achieve Life Sciences helps investors to forecast how Achieve stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Achieve Life more accurately as focusing exclusively on Achieve Life's fundamentals will not take into account other important factors: Achieve Life Sciences Company Current Valuation Analysis
Achieve Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Achieve Life Current Valuation | 121 M |
Most of Achieve Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achieve Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Achieve Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Achieve Life is extremely important. It helps to project a fair market value of Achieve Stock properly, considering its historical fundamentals such as Current Valuation. Since Achieve Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Achieve Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Achieve Life's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Achieve Life Sciences has a Current Valuation of 121 M. This is 99.16% lower than that of the Biotechnology sector and 97.4% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.27% higher than that of the company.
Achieve Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achieve Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achieve Life could also be used in its relative valuation, which is a method of valuing Achieve Life by comparing valuation metrics of similar companies.Achieve Life is currently under evaluation in current valuation category among its peers.
Achieve Life ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Achieve Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Achieve Life's managers, analysts, and investors.Environmental | Governance | Social |
Achieve Fundamentals
| Return On Equity | -1.86 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | 121 M | ||||
| Shares Outstanding | 34.39 M | ||||
| Shares Owned By Insiders | 9.72 % | ||||
| Shares Owned By Institutions | 59.64 % | ||||
| Number Of Shares Shorted | 3.32 M | ||||
| Price To Earning | (0.03) X | ||||
| Price To Book | 4.91 X | ||||
| EBITDA | (26.73 M) | ||||
| Net Income | (29.82 M) | ||||
| Cash And Equivalents | 29.38 M | ||||
| Cash Per Share | 3.03 X | ||||
| Total Debt | 16.73 M | ||||
| Debt To Equity | 1.18 % | ||||
| Current Ratio | 5.81 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | (24.48 M) | ||||
| Short Ratio | 26.81 X | ||||
| Earnings Per Share | (1.12) X | ||||
| Target Price | 16.44 | ||||
| Number Of Employees | 22 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 154.07 M | ||||
| Total Asset | 19.37 M | ||||
| Retained Earnings | (165.75 M) | ||||
| Working Capital | (3.83 M) | ||||
| Current Asset | 22.54 M | ||||
| Current Liabilities | 9.1 M | ||||
| Net Asset | 19.37 M |
About Achieve Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achieve Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achieve Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achieve Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.